Remove Clinical Development Remove Gene Silencing Remove Life Science Remove RNA
article thumbnail

Vevye: A New Cyclosporine Solution for Dry Eye Disease

XTalks

More Drugs for Dry Eye Disease Are on the Way Several other drugs have recently gained FDA approval or are currently in advanced stages of clinical development for the treatment of dry eye disease. One such approved medication is Miebo , an ophthalmic solution developed by Bausch + Lomb and Novaliq.

article thumbnail

2020 review – Pharma’s progress outside of COVID-19

pharmaphorum

It has been a year dominated by the pandemic and many life sciences research projects were put on hold as big pharma turned its attention to vaccines and therapies. It was the third approval from Alnylam’s pipeline of RNA interference therapeutics to make it to market.

article thumbnail

The trends driving ELRIG Drug Discovery 2022

Drug Discovery World

Taking place at the ExCel in London from 4-5 October, ELRIG Drug Discovery 2022 is set to provide visitors with access to the latest trends, technologies and expertise driving the life sciences sector. . Knockout’ mice are bred in a laboratory with specific genes silenced or ‘knocked out’.